Login / Signup

CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer.

Wenjie ZhuZihan ZhaoBaofu FengWenhao YuJi LiHongqian GuoRong Yang
Published in: OncoTargets and therapy (2021)
CD39 may be a potential prognostic marker in BLCA, and CD8+CD39+ T cells may be selected as tumor-reactive and killing T cells for TILs therapy.
Keyphrases
  • nk cells
  • stem cells
  • climate change
  • human health
  • cell therapy
  • muscle invasive bladder cancer